---
title: "Canopy Growth Faces Downside Risk if Uncertain MTL Deal Fails to Close, Analyst Warns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275195845.md"
description: "Canopy Growth (CGC) faces downside risk if the uncertain MTL deal fails to close, as noted by an analyst. The completion of the MTL Arrangement is uncertain due to pending shareholder and regulatory approvals. If these conditions are not met, the acquisition may not close, potentially leading to a decline in CGC's share price. The average stock price target is $2.99, indicating a 171.82% upside potential, but current valuations may assume successful deal completion."
datetime: "2026-02-07T06:01:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275195845.md)
  - [en](https://longbridge.com/en/news/275195845.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275195845.md)
---

# Canopy Growth Faces Downside Risk if Uncertain MTL Deal Fails to Close, Analyst Warns

Canopy Growth (CGC) has disclosed a new risk, in the Corporate Activity and Growth category.

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The analyst notes that the completion of the MTL Arrangement remains uncertain because all conditions precedent, including MTL shareholder and regulatory approvals, may not be satisfied or waived. He observes that there is no assurance as to whether these conditions will be met, or, if they are met, the timing of such satisfaction. He further highlights that failure to satisfy these conditions could result in the acquisition of MTL not closing. In that scenario, he believes the price of Canopy Growth’s shares could decline, particularly if the current valuation assumes successful completion of the acquisition and realization of its anticipated benefits.

The average CGC stock price target is $2.99, implying 171.82% upside potential.

To learn more about Canopy Growth’s risk factors, click here.

### Related Stocks

- [TCNNF.US](https://longbridge.com/en/quote/TCNNF.US.md)
- [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md)
- [CNGL.US](https://longbridge.com/en/quote/CNGL.US.md)

## Related News & Research

- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)
- [Do Wall Street Analysts Like Hasbro Stock?](https://longbridge.com/en/news/287019001.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)